Standalone revenues grew 13.4% YoY to | 1910.4 crore (I-direct estimate: | 1921.6 crore) on the back of 16.7% YoY growth in the pharmacy business to | 892.1 crore (I-direct estimate: | 908.7 crore) and 10.7% YoY growth in the healthcare business to | 1019 crore (Idirect estimate: | 1013.2 crore) EBITDA margins improved 156 bps YoY to 11.9% (I-direct estimate: 11.5%) mainly due to lower other expenditure. EBITDA grew 30.5% YoY at | 226.7 crore (I-direct estimate: | 220.3 crore) Net profit grew 70.9% to | 60.2 crore (I-direct estimate: | 71.9 crore)...